{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T22:29:08Z","timestamp":1792016948140,"version":"4.4.0"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Major Scientific and Technological Special Project","award":["2013ZX09103003-011"],"award-info":[{"award-number":["2013ZX09103003-011"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.antiviral.2017.05.005","type":"journal-article","created":{"date-parts":[[2017,5,18]],"date-time":"2017-05-18T18:34:26Z","timestamp":1495132466000},"page":"57-69","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["A single intranasal administration of virus-like particle vaccine induces an efficient protection for mice against human respiratory syncytial virus"],"prefix":"10.1016","volume":"144","author":[{"given":"Yue-Ying","family":"Jiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-Hui","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Fei","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9966-5691","authenticated-orcid":false,"given":"Xiu-Juan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Dong","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang-Lei","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqiang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Sheng","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.antiviral.2017.05.005_bib1","doi-asserted-by":"crossref","first-page":"4829","DOI":"10.1074\/jbc.M110.191437","article-title":"T\u00a0Cell receptor clonotype influences epitope hierarchy in the CD8+ T cell response to respiratory syncytial virus infection","volume":"286","author":"Billam","year":"2011","journal-title":"J.\u00a0Biol. Chem."},{"issue":"13","key":"10.1016\/j.antiviral.2017.05.005_bib2","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/j.vaccine.2013.11.032","article-title":"A\u00a0recombinant anchorless respiratory syncytial virus (RSV) fusion (F) protein\/monophosphoryl lipid A (MPL) vaccine protects against RSV-induced replication and lung pathology","volume":"32","author":"Blanco","year":"2014","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.antiviral.2017.05.005_bib3","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/sj.gt.3300383","article-title":"Gene transfer into enteric neurons of the rat small intestine in organ culture using a replication defective recombinant herpes simplex virus type 1 (HSV1) vector, but not recombinant adenovirus vectors","volume":"4","author":"Brown","year":"1997","journal-title":"Gene Ther."},{"issue":"7","key":"10.1016\/j.antiviral.2017.05.005_bib4","doi-asserted-by":"crossref","first-page":"e41666","DOI":"10.1371\/journal.pone.0041666","article-title":"Regulation of TB vaccine-induced airway luminal T cells by respiratory exposure to endotoxin","volume":"7","author":"Chen","year":"2012","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.antiviral.2017.05.005_bib5","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1128\/CVI.00720-15","article-title":"Novel respiratory syncytial virus-like particle vaccine composed of the postfusion and prefusion conformations of the F Glycoprotein","volume":"23","author":"Cimica","year":"2016","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.antiviral.2017.05.005_bib6","series-title":"Fields Virology","first-page":"1601","article-title":"Respiratory syncytial virus and metapneumovirus","author":"Collins","year":"2007"},{"key":"10.1016\/j.antiviral.2017.05.005_bib7","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1186\/s12967-015-0705-8","article-title":"Cotton rat immune responses to virus-like particles containing the pre-fusion form of respiratory syncytial virus fusion protein","volume":"13","author":"Cullen","year":"2015","journal-title":"J.\u00a0Transl. Med."},{"issue":"1","key":"10.1016\/j.antiviral.2017.05.005_bib8","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3390\/v9010013","article-title":"Adenoviral vectors armed with cell fusion-inducing proteins as anti-cancer agents","volume":"9","author":"Del Papa","year":"2017","journal-title":"Viruses"},{"issue":"4","key":"10.1016\/j.antiviral.2017.05.005_bib9","doi-asserted-by":"crossref","first-page":"555","DOI":"10.2217\/nnm.10.29","article-title":"Ambiguities in applying traditional Limulus Amebocyte Lysate tests to quantify endotoxin in nanoparticle formulations","volume":"5","author":"Dobrovolskaia","year":"2010","journal-title":"Nanomedicine"},{"issue":"1","key":"10.1016\/j.antiviral.2017.05.005_bib10","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.virol.2005.09.020","article-title":"Replication-defective viruses as vaccines and vaccine vectors","volume":"344","author":"Dudek","year":"2006","journal-title":"Virology"},{"issue":"11","key":"10.1016\/j.antiviral.2017.05.005_bib11","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.2217\/fmb-2016-0106","article-title":"Respiratory syncytial virus vaccines: an update on those in the immediate pipeline","volume":"11","author":"Esposito","year":"2016","journal-title":"Future Microbiol."},{"issue":"4","key":"10.1016\/j.antiviral.2017.05.005_bib12","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.bbrc.2009.02.075","article-title":"Intranasal immunization with a replication-deficient adenoviral vector expressing the fusion glycoprotein of respiratory syncytial virus elicits protective immunity in BALB\/c mice","volume":"381","author":"Fu","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.antiviral.2017.05.005_bib13","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.bbrc.2009.11.152","article-title":"Intranasal vaccination with a helper-dependent adenoviral vector enhances transgene-specific immune responses in BALB\/c mice","volume":"391","author":"Fu","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.antiviral.2017.05.005_bib14","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.bbrc.2010.03.144","article-title":"A\u00a0prime-boost vaccination strategy using attenuated Salmonella typhimurium and a replication-deficient recombinant adenovirus vector elicits protective immunity against human respiratory syncytial virus","volume":"395","author":"Fu","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.antiviral.2017.05.005_bib15","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/1743-422X-10-183","article-title":"Intranasal immunization with a helper-dependent adenoviral vector expressing the codon-optimized fusion glycoprotein of human respiratory syncytial virus elicits protective immunity in BALB\/c mice","volume":"10","author":"Fu","year":"2013","journal-title":"Virol. J."},{"key":"10.1016\/j.antiviral.2017.05.005_bib16","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.antiviral.2014.02.003","article-title":"Sublingual administration of a helper-dependent adenoviral vector expressing the codon-optimized soluble fusion glycoprotein of human respiratory syncytial virus elicits protective immunity in mice","volume":"105","author":"Fu","year":"2014","journal-title":"Antivir. Res."},{"issue":"4","key":"10.1016\/j.antiviral.2017.05.005_bib17","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1099\/0022-1317-83-4-753","article-title":"Respiratory syncytial virus matrix protein associates with nucleocapsids in infected cells","volume":"83","author":"Ghildyal","year":"2002","journal-title":"J.\u00a0General Virol."},{"issue":"7","key":"10.1016\/j.antiviral.2017.05.005_bib18","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1007\/s00705-003-0112-y","article-title":"The matrix protein of Human respiratory syncytial virus localises to the nucleus of infected cells and inhibits transcription","volume":"148","author":"Ghildyal","year":"2003","journal-title":"Arch. Virol."},{"issue":"5","key":"10.1016\/j.antiviral.2017.05.005_bib19","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1574-6976.2006.00025.x","article-title":"Central role of the respiratory syncytial virus matrix protein in infection","volume":"30","author":"Ghildyal","year":"2006","journal-title":"FEMS Microbiol. Rev."},{"issue":"5","key":"10.1016\/j.antiviral.2017.05.005_bib20","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/mi.2010.31","article-title":"Mucosal delivery of human papillomavirus pseudovirus-encapsidated plasmids improves the potency of DNA vaccination","volume":"3","author":"Graham","year":"2010","journal-title":"Mucosal Immunol."},{"issue":"4","key":"10.1016\/j.antiviral.2017.05.005_bib21","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1080\/21645515.2015.1011993","article-title":"Protection conferred by virus-like particle vaccines against respiratory syncytial virus infection in mice by intranasal vaccination","volume":"11","author":"Gu","year":"2015","journal-title":"Hum. Vaccines Immunother."},{"issue":"25","key":"10.1016\/j.antiviral.2017.05.005_bib22","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1056\/NEJM200106213442507","article-title":"Respiratory syncytial virus and parainfluenza virus","volume":"344","author":"Hall","year":"2001","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"Pt 8","key":"10.1016\/j.antiviral.2017.05.005_bib23","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1099\/vir.0.80131-0","article-title":"Human CD8(+) T cell responses against five newly identified respiratory syncytial virus-derived epitopes","volume":"85","author":"Heidema","year":"2004","journal-title":"J.\u00a0Gen. Virol."},{"issue":"2","key":"10.1016\/j.antiviral.2017.05.005_bib24","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1006\/viro.2002.1540","article-title":"Sorting of the respiratory syncytial virus matrix protein into detergent-resistant structures is dependent on cell-surface expression of the glycoproteins","volume":"300","author":"Henderson","year":"2002","journal-title":"Virology"},{"issue":"26","key":"10.1016\/j.antiviral.2017.05.005_bib25","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.1016\/j.vaccine.2016.03.109","article-title":"Advances in RSV vaccine research and development - a global agenda","volume":"34","author":"Higgins","year":"2016","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.antiviral.2017.05.005_bib26","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.coi.2012.03.014","article-title":"Vaccines against mucosal infections","volume":"24","author":"Holmgren","year":"2012","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.antiviral.2017.05.005_bib27","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.imlet.2016.09.011","article-title":"DNA vaccine encoding central conserved region of G protein induces Th1 predominant immune response and protection from RSV infection in mice","volume":"179","author":"Hua","year":"2016","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.antiviral.2017.05.005_bib28","series-title":"Vaccines","first-page":"1283","article-title":"Respiratory syncytial virus and parainfluenza virus vaccines","author":"Karron","year":"2008"},{"issue":"4","key":"10.1016\/j.antiviral.2017.05.005_bib29","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1093\/oxfordjournals.aje.a120955","article-title":"Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine","volume":"89","author":"Kim","year":"1969","journal-title":"Am. J. Epidemiol."},{"issue":"22","key":"10.1016\/j.antiviral.2017.05.005_bib30","doi-asserted-by":"crossref","first-page":"11692","DOI":"10.1128\/JVI.02018-15","article-title":"Virus-like particle vaccine Containing the F Protein of respiratory syncytial virus confers protection without pulmonary disease by modulating specific subsets of dendritic cells and effector T cells","volume":"89","author":"Kim","year":"2015","journal-title":"J.\u00a0Virol."},{"issue":"13","key":"10.1016\/j.antiviral.2017.05.005_bib31","doi-asserted-by":"crossref","first-page":"7602","DOI":"10.1128\/JVI.00256-14","article-title":"Structural analysis of respiratory syncytial virus reveals the position of M2-1 between the matrix protein and the ribonucleoprotein complex","volume":"88","author":"Kiss","year":"2014","journal-title":"J.\u00a0Virol."},{"issue":"5","key":"10.1016\/j.antiviral.2017.05.005_bib32","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/80833","article-title":"Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus","volume":"1","author":"Kurt-Jones","year":"2000","journal-title":"Nat. Immunol."},{"issue":"27","key":"10.1016\/j.antiviral.2017.05.005_bib33","doi-asserted-by":"crossref","first-page":"11133","DOI":"10.1073\/pnas.1309070110","article-title":"Architecture of respiratory syncytial virus revealed by electron cryotomography","volume":"110","author":"Liljeroos","year":"2013","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"3","key":"10.1016\/j.antiviral.2017.05.005_bib34","doi-asserted-by":"crossref","first-page":"e1005486","DOI":"10.1371\/journal.ppat.1005486","article-title":"A\u00a0numerically subdominant CD8 T cell response to matrix protein of respiratory syncytial virus controls infection with limited immunopathology","volume":"12","author":"Liu","year":"2016","journal-title":"PLoS Pathog."},{"issue":"1","key":"10.1016\/j.antiviral.2017.05.005_bib35","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.virol.2006.04.023","article-title":"Characterization of the CD8+ T cell responses directed against respiratory syncytial virus during primary and secondary infection in C57BL\/6 mice","volume":"352","author":"Lukens","year":"2006","journal-title":"Virology"},{"issue":"8","key":"10.1016\/j.antiviral.2017.05.005_bib36","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/nri3251","article-title":"Recent progress in mucosal vaccine development: potential and limitations","volume":"12","author":"Lycke","year":"2012","journal-title":"Nat. Rev. Immunol."},{"issue":"9","key":"10.1016\/j.antiviral.2017.05.005_bib37","doi-asserted-by":"crossref","first-page":"4513","DOI":"10.1128\/JVI.01931-09","article-title":"Assembly and biological and immunological properties of Newcastle disease virus-like particles","volume":"84","author":"McGinnes","year":"2010","journal-title":"J.\u00a0Virol."},{"issue":"1","key":"10.1016\/j.antiviral.2017.05.005_bib38","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1128\/JVI.01861-10","article-title":"Assembly and immunological properties of Newcastle disease virus-like particles containing the respiratory syncytial virus F and G Proteins","volume":"85","author":"McGinnes","year":"2011","journal-title":"J.\u00a0Virol."},{"issue":"6158","key":"10.1016\/j.antiviral.2017.05.005_bib39","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1126\/science.1243283","article-title":"Structure-based design of a fusion glycoprotein vaccine for respiratory syncytial virus","volume":"342","author":"McLellan","year":"2013","journal-title":"Science"},{"issue":"23\u201324","key":"10.1016\/j.antiviral.2017.05.005_bib40","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.1016\/S0264-410X(02)00217-7","article-title":"Plasmid DNA encoding the respiratory syncytial virus G protein protects against RSV-induced airway hyperresponsiveness","volume":"20","author":"Miller","year":"2002","journal-title":"Vaccine"},{"issue":"24","key":"10.1016\/j.antiviral.2017.05.005_bib41","doi-asserted-by":"crossref","first-page":"13710","DOI":"10.1128\/JVI.01351-07","article-title":"Venezuelan equine encephalitis virus replicon particles encoding respiratory syncytial virus surface glycoproteins induce protective mucosal responses in mice and cotton rats","volume":"81","author":"Mok","year":"2007","journal-title":"J.\u00a0Virol."},{"issue":"11","key":"10.1016\/j.antiviral.2017.05.005_bib42","doi-asserted-by":"crossref","first-page":"4441","DOI":"10.1073\/pnas.0805740106","article-title":"Surface features of a Mononegavirales matrix protein indicate sites of membrane interaction","volume":"106","author":"Money","year":"2009","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"2","key":"10.1016\/j.antiviral.2017.05.005_bib43","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1128\/JVI.01709-09","article-title":"Newcastle disease virus-like particles containing respiratory syncytial virus G protein induced protection in BALB\/c mice, with No evidence of immunopathology","volume":"84","author":"Murawski","year":"2010","journal-title":"J.\u00a0Virol."},{"issue":"9","key":"10.1016\/j.antiviral.2017.05.005_bib44","doi-asserted-by":"crossref","first-page":"4232","DOI":"10.1128\/JVI.64.9.4232-4241.1990","article-title":"Cytolytic T-lymphocyte responses to respiratory syncytial virus: effector cell phenotype and target proteins","volume":"64","author":"Nicholas","year":"1990","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2017.05.005_bib45","series-title":"Novavax Announces Topline RSV F Vaccine Data from Two Clinical Trials in Older Adults","year":"2016"},{"issue":"3 Pt 1","key":"10.1016\/j.antiviral.2017.05.005_bib46","first-page":"531","article-title":"Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants","volume":"102","year":"1998","journal-title":"IMpact-RSV Study Group. Pediatr."},{"issue":"1","key":"10.1016\/j.antiviral.2017.05.005_bib47","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jcv.2007.10.024","article-title":"Respiratory syncytial virus (RSV) vaccines\u2014two steps back for one leap forward","volume":"41","author":"Power","year":"2008","journal-title":"J.\u00a0Clin. Virol."},{"key":"10.1016\/j.antiviral.2017.05.005_bib48","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.antiviral.2016.05.001","article-title":"Chimeric virus-like particles containing a conserved region of the G protein in combination with a single peptide of the M2 protein confer protection against respiratory syncytial virus infection","volume":"131","author":"Qiao","year":"2016","journal-title":"Antivir. Res."},{"issue":"7","key":"10.1016\/j.antiviral.2017.05.005_bib49","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1093\/infdis\/jir474","article-title":"Viruslike particle vaccine induces protection against respiratory syncytial virus infection in mice","volume":"204","author":"Quan","year":"2011","journal-title":"J.\u00a0Infect. Dis."},{"issue":"2","key":"10.1016\/j.antiviral.2017.05.005_bib50","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.virol.2005.04.032","article-title":"Identification of an H-2Db-restricted CD8+ cytotoxic T lymphocyte epitope in the matrix protein of respiratory syncytial virus","volume":"337","author":"Rutigliano","year":"2005","journal-title":"Virology"},{"issue":"4","key":"10.1016\/j.antiviral.2017.05.005_bib51","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1172\/JCI78450","article-title":"Palivizumab epitope\u2013displaying virus-like particles protect rodents from RSV challenge","volume":"125","author":"Schickli","year":"2015","journal-title":"J.\u00a0Clin. Investig."},{"issue":"21","key":"10.1016\/j.antiviral.2017.05.005_bib52","doi-asserted-by":"crossref","first-page":"11654","DOI":"10.1128\/JVI.01510-12","article-title":"Long-term and memory immune responses in mice against Newcastle disease virus-like particles containing respiratory syncytial virus glycoprotein ectodomains","volume":"86","author":"Schmidt","year":"2012","journal-title":"J.\u00a0Virol."},{"issue":"17","key":"10.1016\/j.antiviral.2017.05.005_bib53","doi-asserted-by":"crossref","first-page":"10165","DOI":"10.1128\/JVI.01250-14","article-title":"Modification of the respiratory syncytial virus F protein in virus-like particles impacts Generation of B Cell memory","volume":"88","author":"Schmidt","year":"2014","journal-title":"J.\u00a0Virol."},{"issue":"3","key":"10.1016\/j.antiviral.2017.05.005_bib54","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1084\/jem.186.3.421","article-title":"Virus-specific CD8+ T lymphocytes downregulate T helper cell type 2 cytokine secretion and pulmonary eosinophilia during experimental murine respiratory syncytial virus infection","volume":"186","author":"Srikiatkhachorn","year":"1997","journal-title":"J.\u00a0Exp. Med."},{"issue":"300","key":"10.1016\/j.antiviral.2017.05.005_bib55","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1126\/scitranslmed.aac5757","article-title":"Efficacy of a virus-vectored vaccine against human and bovine respiratory syncytial virus infections","volume":"7","author":"Taylor","year":"2015","journal-title":"Sci. Transl. Med."},{"issue":"9","key":"10.1016\/j.antiviral.2017.05.005_bib56","doi-asserted-by":"crossref","first-page":"4378","DOI":"10.1128\/JCM.41.9.4378-4381.2003","article-title":"Applicability of a real-time quantitative PCR assay for diagnosis of respiratory syncytial virus infection in immunocompromised adults","volume":"41","author":"van Elden","year":"2003","journal-title":"J.\u00a0Clin. Microbiol."},{"issue":"7","key":"10.1016\/j.antiviral.2017.05.005_bib57","doi-asserted-by":"crossref","first-page":"e0130755","DOI":"10.1371\/journal.pone.0130755","article-title":"Mammalian cell-derived respiratory syncytial virus-like particles protect the lower as well as the upper respiratory tract","volume":"10","author":"Walpita","year":"2015","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.antiviral.2017.05.005_bib58","doi-asserted-by":"crossref","first-page":"e0130829","DOI":"10.1371\/journal.pone.0130829","article-title":"Recombinant soluble respiratory syncytial virus F protein that lacks heptad repeat B, contains a GCN4 trimerization motif and is not cleaved displays prefusion-like characteristics","volume":"10","author":"Widjaja","year":"2015","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.antiviral.2017.05.005_bib59","doi-asserted-by":"crossref","first-page":"e9784","DOI":"10.1371\/journal.pone.0009784","article-title":"Mammalian expression of virus-like particles for advanced mimicry of authentic influenza virus","volume":"5","author":"Wu","year":"2010","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.antiviral.2017.05.005_bib60","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1089\/hum.2007.053","article-title":"Oral respiratory syncytial virus (RSV) DNA vaccine expressing RSV F protein delivered by AttenuatedSalmonella typhimurium","volume":"18","author":"Xie","year":"2007","journal-title":"Hum. Gene Ther."},{"issue":"8","key":"10.1016\/j.antiviral.2017.05.005_bib61","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1080\/21645515.2016.1165908","article-title":"Adenoviral vector-based strategies against infectious disease and cancer","volume":"12","author":"Zhang","year":"2016","journal-title":"Hum. Vaccines Immunother."},{"issue":"2","key":"10.1016\/j.antiviral.2017.05.005_bib62","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1158\/1078-0432.CCR-07-1176","article-title":"Effects of plasmid-based stat3-specific short hairpin RNA and GRIM-19 on PC-3M tumor cell growth","volume":"14","author":"Zhang","year":"2008","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.antiviral.2017.05.005_bib63","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.pep.2011.09.011","article-title":"Purification of human respiratory syncytial virus fusion glycoprotein","volume":"81","author":"Zheng","year":"2012","journal-title":"Protein Expr. Purif."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354217300189?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354217300189?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,8]],"date-time":"2020-10-08T02:13:35Z","timestamp":1602123215000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354217300189"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":63,"alternative-id":["S0166354217300189"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2017.05.005","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A single intranasal administration of virus-like particle vaccine induces an efficient protection for mice against human respiratory syncytial virus","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2017.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}